This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Mathilda and Terence Kennedy Institute of Rheumatology, The Kennedy Institute of Rheumatology, The Kennedy Institute for Rheumatology. Active years: 1998-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 10 
3 out of 4 
1 out of 1 Years Active: 1998-2013
Title: The Innovations of Ravinder Nath Maini
Introduction
Ravinder Nath Maini is a prominent inventor based in London, GB. He has made significant contributions to the field of rheumatology, particularly in the treatment of TNF-mediated diseases. With a total of 8 patents to his name, Maini's work has had a profound impact on medical science.
Latest Patents
One of his latest patents focuses on the concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate. This patent discloses methods for treating and/or preventing TNF-mediated diseases in individuals. The composition includes methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases addressed in this patent include rheumatoid arthritis, Crohn's disease, and both acute and chronic immune diseases associated with transplantation.
Career Highlights
Throughout his career, Ravinder Nath Maini has worked with esteemed institutions such as the Mathilda and Terence Kennedy Institute of Rheumatology and The Kennedy Institute of Rheumatology. His research has been pivotal in advancing the understanding and treatment of autoimmune diseases.
Collaborations
Maini has collaborated with notable colleagues, including Marc Feldmann and Marc Feldman. Their joint efforts have contributed to significant advancements in rheumatology and the development of innovative treatment methods.
Conclusion
Ravinder Nath Maini's contributions to the field of rheumatology through his patents and collaborations have established him as a key figure in medical innovation. His work continues to influence the treatment of TNF-mediated diseases, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile